Antinociceptive effect of berberine on visceral hypersensitivity in rats

World Journal of Gastroenterology

Volumn 19, Issue 28, 2013, Pages 4582-4589

  Tang, Qing Lin ^a   Lai, Min Ling ^a   Zhong, Yuan Fu ^a   Wang, Ai Min ^a   Su, Jun Kai ^a   Zhang, Ming Qing ^a  

^a Digestive Endoscopy Center of Nanjing Military Command   (China)

Author keywords

Berberine; Irritable bowel syndrome; Nitric oxide; Visceral hypersensitivity

Indexed keywords

AMINOGUANIDINE; BERBERINE; NITRIC OXIDE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL MOTILITY; HISTOLOGY; HYPERSENSITIVITY; IRRITABLE COLON; MALE; NOCICEPTIVE PAIN; NONHUMAN; RAT; WITHDRAWAL REFLEX;

EID: 84880776858     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i28.4582     Document Type: Article

References (34)

1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131 [PMID: 12454866 DOI: 10.1053/gast.2002.37095]
2. Kuiken SD, Klooker TK, Tytgat GN, Lei A, Boeckxstaens GE. Possible role of nitric oxide in visceral hypersensitivity in patients with irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 115-122 [PMID: 16420289 DOI: 10.1111/ j.1365-2982.2005.00731.x]
3. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther 2002; 16: 1407-1430 [PMID: 12182741 DOI: 10.1046/j.1365-2036.2002.01305.x]
4. La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS. Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome. World J Gastroenterol 2005; 11: 237-241 [PMID: 15633223]
5. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/ j.gastro.2005.11.061]
6. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 2002; 51 Suppl 1: i67-i71 [PMID: 12077070 DOI: 10.1136/gut.51.suppl_1.i67]
7. Brookes SJ. Classes of enteric nerve cells in the guinea-pig small intestine. Anat Rec 2001; 262: 58-70 [PMID: 11146429 DOI: 10.1002/1097-0185(20010101)262]
8. Coutinho SV, Gebhart GF. A role for spinal nitric oxide in mediating visceral hyperalgesia in the rat. Gastroenterology 1999; 116: 1399-1408 [PMID: 10348823 DOI: 10.1016/ S0016-5085(99)70504-4]
9. Shamshiri H, Paragomi P, Paydar MJ, Moezi L, Bahadori M, Behfar B, Ardalan FA, Dehpour AR. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway. J Gastroenterol Hepatol 2009; 24: 672-680 [PMID: 19032458 DOI: 10.1111/ j.1440-1746.2008.05652.x]
10. Dai C, Guandalini S, Zhao DH, Jiang M. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Mol Cell Biochem 2012; 362: 43-53 [PMID: 22020749 DOI: 10.1007/ s11010-011-1126-5]
11. Kuiken SD, Tytgat GN, Boeckxstaens GE. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence. Aliment Pharmacol Ther 2005; 21: 633-651 [PMID: 15771750 DOI: 10.1111/j.1365-2036.2005.02392.x]
12. Kong DX, Li XJ, Tang GY, Zhang HY. How many traditional Chinese medicine components have been recognized by modern Western medicine? A chemoinformatic analysis and implications for finding multicomponent drugs. ChemMedChem 2008; 3: 233-236 [PMID: 18022980 DOI: 10.1002/cmdc.20070]
13. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004; 203: 127-137 [PMID: 14732220 DOI: 10.1016/j.canlet.2003.09.002]
14. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YO. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillinresistant Staphylococcus aureus. J Med Food 2005; 8: 454-461 [PMID: 16379555 DOI: 10.1089/jmf.2005.8.454]
15. Letasiová S, Jantová S, Cipák L, Múcková M. Berberineantiproliferative activity in vitro and induction of apoptosis/ necrosis of the U937 and B16 cells. Cancer Lett 2006; 239: 254-262 [PMID: 16229943 DOI: 10.1016/j.canlet.2005.08.024]
16. Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 2007; 258: 230-240 [PMID: 17964072 DOI: 10.1016/ j.canlet.2007.09.007]
17. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, Li F, Tang J, Chen M, Chen J. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism 2007; 56: 405-412 [PMID: 17292731 DOI: 10.1016/ j.metabol.2006.10.025]
18. Gu L, Li N, Li Q, Zhang Q, Wang C, Zhu W, Li J. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells. Fitoterapia 2009; 80: 241-248 [PMID: 19243699 DOI: 10.1016/j.fitote.2009.02.005]
19. Niu L, Qiao W, Hu Z, Li N, Huang Q, Gong J, Li Q, Zhu W, Li J. Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat. Fitoterapia 2011; 82: 323-330 [PMID: 21073932 DOI: 10.1016/j.fitote.2010.11.007]
20. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 2000; 294: 822-829 [PMID: 10945829]
21. Lee IA, Hyun YJ, Kim DH. Berberine ameliorates TNBSinduced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur J Pharmacol 2010; 648: 162-170 [PMID: 20828550 DOI: 10.1016/j.ejphar.2010.08.046]
22. Zhang M, Long Y, Sun Y, Wang Y, Li Q, Wu H, Guo Z, Li Y, Niu Y, Li C, Liu L, Mei Q. Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid. Eur J Pharmacol 2011; 651: 187-196 [PMID: 20969848 DOI: 10.1016/j.ejphar.2010.10.030]
23. Pan LR, Tang Q, Fu Q, Hu BR, Xiang JZ, Qian JQ. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice. Acta Pharmacol Sin 2005; 26: 1334-1338 [PMID: 16225755 DOI: 10.1111/j.1745-7254.2005.00186.x]
24. Xu MG, Wang JM, Chen L, Wang Y, Yang Z, Tao J. Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology 2009; 112: 279-286 [PMID: 18815446 DOI: 10.1159/000157336]
25. Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM, Xu A. Berberine prevents hyperglycemiainduced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 2009; 82: 484-492 [PMID: 19251722 DOI: 10.1093/cvr/cvp078]
26. Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ, Zhang GL. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine-and phenobarbital-treated rats. Biomed Pharmacother 2008; 62: 567-572 [PMID: 17418998 DOI: 10.1016/j.biopha.2007.02.009]
27. Zhu F, Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 2006; 7: 78 [PMID: 17137520 DOI: 10.1186/1471-2202-7-78]
28. Cernáková M, Kostálová D. Antimicrobial activity of berberine--a constituent of Mahonia aquifolium. Folia Microbiol (Praha) 2002; 47: 375-378 [PMID: 12422513 DOI: 10.1007/ BF02818693]
29. Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 2002; 91: 193-197 [PMID: 12530470 DOI: 10.1034/ j.1600-0773.2002.t01-1-910403.x]
30. Kreiss C, Toegel S, Bauer AJ. Alpha2-adrenergic regulation of NO production alters postoperative intestinal smooth muscle dysfunction in rodents. Am J Physiol Gastrointest Liver Physiol 2004; 287: G658-G666 [PMID: 15331355 DOI: 10.1152/ajpgi.00526.2003]
31. Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2004; 286: G225-G233 [PMID: 14715517 DOI: 10.1152/ajpgi.00447.2002]
32. Fritz E, Hammer J, Schmidt B, Eherer AJ, Hammer HF. Stimulation of the nitric oxide-guanosine 3', 5'-cyclic monophosphate pathway by sildenafil: effect on rectal muscle tone, distensibility, and perception in health and in irritable bowel syndrome. Am J Gastroenterol 2003; 98: 2253-2260 [PMID: 14572576 DOI: 10.1016/S0002-9270(03)00624-5]
33. Kuiken SD, Vergeer M, Heisterkamp SH, Tytgat GN, Boeckxstaens GE. Role of nitric oxide in gastric motor and sensory functions in healthy subjects. Gut 2002; 51: 212-218 [PMID: 12117882 DOI: 10.1136/gut.51.2.212]
34. Xu JR, Luo JY, Shang L, Kong WM. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models. Chin J Dig Dis 2006; 7: 89-96 [PMID: 16643336 DOI: 10.1111/j.1443-9573.2006.00248.x]